Search Results

• • 1,858 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Nodular episcleritis after laser in situ keratomileusis in patient with systemic lupus erythematosus

  Author:Mohammad Al-AmryFrom:Oman Journal of Ophthalmology (Vol. 6, Issue 1) Peer-Reviewed

  January-April 2013432 words Article 1330LByline: Mohammad. Al-Amry Sir, Laser in situ keratomileusis (LASIK) is safe and efficacious for the treatment of refractive error. However, controversy remains regarding LASIK for patients with autoimmune...

• The one-and-a-half syndrome as the presenting sign of systemic lupus erythematosus

  Authors:Payam Sasannejad, Nahid Olfati, Mohsen Sabi, and Ali JuibaryFrom:Neurology India (Vol. 62, Issue 3) Peer-Reviewed

  May-June 2014787 words Clinical report, Let... 1440LByline: Payam. Sasannejad, Nahid. Olfati, Mohsen. Sabi, Ali. Juibary Sir, One-and-a-half syndrome (OHS) is characterized by an internuclear ophthalmoplegia (INO) and lateral gaze palsy due to the involvement of...

• Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy

  Authors:Rosanna Coppo, Licia Peruzzi, Alessandro Amore, Silvana Martino, Luca Vergano, Inna Lastauka, et al.From:Pediatric Nephrology (Vol. 30, Issue 1) Peer-Reviewed

  Jan. 20153,332 words Report 1500LBackground Treatment of systemic lupus erythematosus (SLE) with severe diffuse proliferative nephritis is often challenging, particularly in small children in whom a genetic conditioning is likely to play a role. The...

• Serum cystatin C, urinary neutrophil gelatinase-associated lipocalin and N-acetyl-beta-D-glucosaminidase in juvenile and adult patients with systemic lupus erythematosus: Correlation with clinical manifestations, disease activity and damage

  Authors:Tamer Gheita, Abeer Abd El Baky, Heba Assal, Tarek Farid, Inas Rasheed, and Eman ThabetFrom:Saudi Journal of Kidney Diseases and Transplantation (Vol. 26, Issue 3) Peer-Reviewed

  May-June 20154,246 words Report 2060LByline: Tamer. Gheita, Abeer. Abd El Baky, Heba. Assal, Tarek. Farid, Inas. Rasheed, Eman. Thabet Lupus nephritis (LN) is a potentially devastating outcome of systemic lupus erythematosus (SLE). It is important to...

• Upper extremity subclinical autonomic and peripheral neuropathy in systemic lupus erythematosus

  Authors:Mahmoud Fathalla and Mohja El-BadawyFrom:Egyptian Rheumatology and Rehabilitation (Vol. 42, Issue 2) Peer-Reviewed

  April-June 20154,241 words Clinical report 1390LByline: Mahmoud. Fathalla, Mohja. El-Badawy Background Systemic lupus erythematosus (SLE) is an autoimmune, multiorgan disease that affects connective tissues of many organs or systems, including the nervous system,...

• The association among antioxidant enzymes, autoantibodies, and disease severity score in systemic lupus erythematosus: comparison of neuropsychiatric and nonneuropsychiatric groups

  Authors:Yu-Jih Su, Tien-Tsai Cheng, Chung-Jen Chen, Wen-Chan Chiu, Wen- Neng Chang, Nai-Wen Tsai, et al.From:BioMed Research InternationalPeer-Reviewed

  Annual 20143,499 words Report 1300LBackground. Antioxidative capacity plays an important role in the severity of systemic lupus erythematosus (SLE), which is characterized by autoantibodies. This study aimed to determine the relationship among...

• Domains and Determinants of Quality of Life in Schizophrenia and Systemic Lupus Erythematosus

  Authors:Rajiv Radhakrishnan, Jayakumar Menon, Milanduth Kanigere, Mysore Ashok, Vineeta Shobha, and R. GalgaliFrom:Indian Journal of Psychological Medicine (Vol. 34, Issue 1)

  January-March 20124,241 words Report 1690LByline: Rajiv. Radhakrishnan, Jayakumar. Menon, Milanduth. Kanigere, Mysore. Ashok, Vineeta. Shobha, R. Galgali Background: The World Health Organization Quality of Life-Bref (WHOQOL-Bref) scale was designed to...

• Hematopoietic stem cell transplantation for systemic lupus erythematosus

  Author:Alberto M. MarmontFrom:Clinical and Developmental ImmunologyPeer-Reviewed

  September-October 20127,920 words Clinical report 1530LTwo streams of research are at the origin of the utilization of hematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (SADs). The allogeneic approach came from experimental studies on lupus mice,...

• The impact of osteopontin gene variations on multiple sclerosis development and progression

  Authors:Cristoforo Comi, Giuseppe Cappellano, Annalisa Chiocchetti, Elisabetta Orilieri, Sara Buttini, Laura Ghezzi, et al.From:Clinical and Developmental ImmunologyPeer-Reviewed

  September-October 20123,514 words Article 1550LOsteopontin is a proinflammatory molecule, modulating TH1 and TH17 responses. Several reports suggest its involvement in multiple sclerosis (MS) pathogenesis. We previously reported that OPN gene variations at the 3'...

• Index provides new insights into lupus cardiac risks

  From:The Journal of Musculoskeletal Medicine (Vol. 28, Issue 2) Peer-Reviewed

  Feb. 2011237 words Brief article, Repor... 1250LDogdu O, Yarlioglues M, Kaya MG, et al, Erciyes University School of Medicine, Kayseri, Turkey, and Gaziosmanpasa University School of Medicine, Tokat, Turkey. Deterioration of heart rate recovery index in patients with...

• Rare neurological syndromes associated with systemic lupus erythematosus/Sistemik lupus eritematozus ile iliskili nadir norolojik sendromlarin birlikteligi

  Authors:Hacer Durmus, Erdem Tuzun, Nilufer Alpay, Sema Icoz, Murat Kurtuncu, and Gulsen Akman DemirFrom:Archives of Neuropsychiatry (Vol. 47, Issue 1) Peer-Reviewed

  Mar. 20101,061 words Report A 68-year-old woman presented with subacute onset of limbic symptoms, cerebellar ataxia and polyneuropathy. While the initial findings were suggestive of a paraneoplastic syndrome, she later developed liver and kidney...

• Vitamin D in systemic lupus erythematosus: potential beyond bone health

  Authors:John A Reynolds and Ian N BruceFrom:International Journal of Clinical Rheumatology (Vol. 4, Issue 3) Peer-Reviewed

  June 20099,289 words Report Author(s): John A Reynolds 1 , Ian N Bruce [[dagger]] 1 KEYWORDS: autoimmunity; calcitriol; cardiovascular disease; musculoskeletal pain; SLE; systemic lupus erythematosus; vitamin D Systemic lupus...

• Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus

  Authors:Sofia de Achaval and Maria E Suarez-AlmazorFrom:International Journal of Clinical Rheumatology (Vol. 5, Issue 3) Peer-Reviewed

  June 20108,498 words Report Author(s): Sofia de Achaval 1 , Maria E Suarez-Almazor [[dagger]] 2 KEYWORDS: adherence; disease-modifying antirheumatic drugs; rheumatoid arthritis; systematic review; systemic lupus erythematosus Treatment...

• Bortezomib: lupus erythematosus tumidus (first report) in an elderly patient: case report

  From:Reactions Weekly (Issue 1276)

  Oct. 31, 2009274 words Brief article, Case ... [*] A 71-year-old woman developed lupus erythematosus tumidus (LET) while receiving bortezomib for multiple myeloma. Following diagnosis of stage IIIA disease in 2007, the woman received cycles of therapy...

• Rituximab: interstitial pneumonitis: case report

  From:Reactions Weekly (Issue 1253)

  May 23, 2009215 words Brief article, Case ... 1060LA 24-year-old woman developed interstitial pneumonitis after receiving rituximab for systemic lupus erythematosus (SLE). The woman's SLE was initially treated with IV methylprednisolone pulse therapy and oral...

• Effect of premature menopause on sexuality

  Author:Alessandra GraziottinFrom:Women's Health (Vol. 3, Issue 4) Peer-Reviewed

  July 200714,458 words Article Author(s): Alessandra Graziottin 1 Keywords: arousal disorders; cancer survivors; desire disorders; dyspareunia; estrogen; hormone therapy; infertility; premature menopause; sexual dysfunction; testosterone...

• Leflunomide in the treatment of rheumatoid arthritis

  Authors:Gary Kunkel and Grant W CannonFrom:Expert Review of Clinical Immunology (Vol. 2, Issue 1) Peer-Reviewed

  Jan. 200611,943 words Article Author(s): Gary Kunkel [[dagger]] 1 , Grant W Cannon 1 Keywords: clinical trials; juvenile rheumatoid arthritis; leflunomide; rheumatoid arthritis Rheumatoid arthritis (RA) is a chronic, disabling disease that...

• Therapy of cutaneous lupus erythematosus

  Authors:Jennie T Clarke and Victoria P WerthFrom:Expert Review of Dermatology (Vol. 1, Issue 1) Peer-Reviewed

  Feb. 200613,494 words Article 1460LAuthor(s): Jennie T Clarke 1 , Victoria P Werth [[dagger]] 2 Keywords: antimalarial therapy; biological therapy; cutaneous lupus; dapsone therapy; erythematosus; immunosuppressant therapy; retinoid therapy;...

• Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies

  Authors:Michael E Burczynski and Andrew J DornerFrom:Pharmacogenomics (Vol. 7, Issue 2) Peer-Reviewed

  Mar. 200611,504 words Report Author(s): Michael E Burczynski [1[dagger]] , Andrew J Dorner Keywords: biomarkers; clinical pharmacogenomics; cell purification tubes; hemogenomics; molecular diagnostics; peripheral blood mononuclear cells;...

• Thrombotic microangiopathic antiphospholipid syndromes: a continuum of conditions?

  Authors:Ronald A Asherson, Ricard Cervera, and Joan T MerrillFrom:Future Rheumatology (Vol. 1, Issue 3) Peer-Reviewed

  June 20067,077 words Report Author(s): Ronald A Asherson 1 , Ricard Cervera 2 , Joan T Merrill 3 Keywords: antiphospholipid antibodies; Asherson's syndrome; HELLP syndrome; microangiopathic antiphospholipid syndrome; thrombotic...